Lisa Maduzia

Title: Innovations by Lisa Maduzia in RNase Inhibition

Introduction

Lisa Maduzia is an accomplished inventor based in Topsfield, MA (US). She has made significant contributions to the field of molecular biology, particularly in the development of RNase inhibitors. Her work is crucial for protecting RNA in biological samples from degradation, which is essential for various research applications.

Latest Patents

Lisa Maduzia holds a patent for RNase inhibitors, which includes compositions, methods, and kits designed to inhibit one or more types of RNase. This innovation allows for the protection of RNA in samples that may be exposed to RNases, either naturally occurring or introduced in laboratory settings. The patent details that multiple types of oligonucleotide RNase inhibitors can be combined to inhibit various RNases simultaneously. Additionally, single oligonucleotides have been identified with inhibitory activity against multiple RNases. These RNase oligonucleotide inhibitors can be immobilized on beads or other surfaces and may be stored in either a lyophilized form or in solution.

Career Highlights

Lisa is currently associated with New England Biolabs, Inc., where she continues to advance her research in molecular biology. Her innovative work has positioned her as a key figure in the development of tools that enhance the reliability of RNA studies.

Collaborations

Throughout her career, Lisa has collaborated with notable colleagues, including Nathan Tanner and Jennifer Ong. These partnerships have further enriched her research and contributed to the advancement of her inventions.

Conclusion

Lisa Maduzia's contributions to the field of RNase inhibition exemplify the importance of innovation in molecular biology. Her patent and ongoing work at New England Biolabs, Inc. highlight her commitment to enhancing research methodologies.